Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action.
Circ Res 106(12):1904-11 (2010) PMID 20448213 PMCID PMC2908245
Human CD34(+) cells have been used in clinical trials for treatment of myocardial infarction (MI). However, it is unknown how long the CD34(+) cells persist in hearts, whether the improvement in cardiac function is sustained, or what are the underlying mechanisms.
DOI: 10.1161/CIRCRESAHA.110.221762
Version: za2963e q8za5 q8zbe q8zc5 q8zd8 q8ze7 q8zf0 q8zgf